Clarivate (NYSE:CLVT) Releases FY 2026 Earnings Guidance

Clarivate (NYSE:CLVT) issued an update on its FY 2026 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 0.700-0.800 for the period, compared to the consensus earnings per share estimate of 0.720. The company issued revenue guidance of $2.3 billion-$2.4 billion, compared to the consensus revenue estimate of $2.4 billion.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on CLVT shares. Wall Street Zen raised shares of Clarivate from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Weiss Ratings restated a “sell (e+)” rating on shares of Clarivate in a report on Wednesday, June 24th. Five analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $3.22.

Clarivate Stock Down 0.6%

Shares of NYSE CLVT opened at $2.58 on Monday. The company’s 50 day moving average price is $2.41 and its 200-day moving average price is $2.58. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.84 and a current ratio of 0.84. Clarivate has a 52-week low of $1.66 and a 52-week high of $4.77. The company has a market capitalization of $1.65 billion, a P/E ratio of -12.26 and a beta of 1.38.

Clarivate (NYSE:CLVT) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.04. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The company had revenue of $585.50 million during the quarter, compared to analysts’ expectations of $569.50 million. During the same period in the prior year, the company posted $0.14 earnings per share. Clarivate’s revenue for the quarter was down 1.4% compared to the same quarter last year. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. Equities analysts forecast that Clarivate will post 0.65 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Atairos Partners GP Inc. boosted its position in shares of Clarivate by 195.3% during the 4th quarter. Atairos Partners GP Inc. now owns 10,232,667 shares of the company’s stock valued at $34,177,000 after purchasing an additional 6,767,667 shares in the last quarter. First Trust Advisors LP bought a new stake in Clarivate in the fourth quarter worth approximately $16,721,000. Balyasny Asset Management L.P. increased its holdings in Clarivate by 827.6% in the third quarter. Balyasny Asset Management L.P. now owns 4,882,593 shares of the company’s stock worth $18,700,000 after purchasing an additional 4,356,232 shares in the last quarter. Bank of America Corp DE increased its holdings in Clarivate by 506.9% in the second quarter. Bank of America Corp DE now owns 2,870,668 shares of the company’s stock worth $12,344,000 after purchasing an additional 2,397,670 shares in the last quarter. Finally, Man Group plc lifted its stake in Clarivate by 228.1% in the second quarter. Man Group plc now owns 3,091,139 shares of the company’s stock valued at $13,292,000 after buying an additional 2,148,943 shares during the period. 85.72% of the stock is owned by institutional investors and hedge funds.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.